OMCL - オムニセル (Omnicell Inc.) オムニセル

 OMCLのチャート


 OMCLの企業情報

symbol OMCL
会社名 Omnicell Inc (オムニセル)
分野(sector) Technology   ハイテク
産業(industry) Computer Manufacturing  
業種 先端医療機器_テクノロジ―   IT・通信(IT_Communications)
概要 事業概要 オムニセル(Omnicell Inc.)は急性期ケア病院の設定から急性期後の熟練した看護と長期ケア施設から家庭へ至るまで、患者中心の投薬及び供給管理のための自動化とビジネス分析ソフトウェアソリューションを提供する。同社は2つの事業を運営する。自動化・分析部門は、投薬・供給分配システム、薬局在庫管理システム及び関連ソフトウェアの設計、製造、販売およびサービス提供に従事する。投薬遵守部門には、消耗薬ブリスターカード、包装機器、薬物同期プラットフォーム、補助的な製品及びサービスの開発、製造、販売が含まれる。同社の製品は、病院環境の外で投薬管理を管理するために使用され、「MTS」、「Surgichem」、「SureMed」、「Omnicell」ブランドのブランド名で販売されている薬物服用製品が含まれる。   オムニセルは、米国の医療関連サ―ビス会社。おもに投薬管理プロセスや医療品管理の合理化を手掛ける。医療施設での薬や医療・外科用品の取得、管理、調剤を有効に行うために、病院や長期ケア環境における自動化・分析・服薬順守ソリュ―ションを提供する。製品とサ―ビスを、病院と病院以外のヘルスケア施設に販売する。   Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
本社所在地 590 East Middlefield Road Mountain View CA 94043 USA
代表者氏名 Randall A. Lipps ランダルA.リップス
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 650-251-6100
設立年月日 33848
市場名 NASDAQ National Market System
ipoyear 2001年
従業員数 2350人
url www.omnicell.com
nasdaq_url https://www.nasdaq.com/symbol/omcl
adr_tso
EBITDA EBITDA(百万ドル) 84.09100
終値(lastsale) 65.895
時価総額(marketcap) 2587694673.15
時価総額 時価総額(百万ドル) 2478.72
売上高 売上高(百万ドル) 756.01800
企業価値(EV) 企業価値(EV)(百万ドル) 2631.322
当期純利益 当期純利益(百万ドル) 26.43900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Omnicell Inc. revenues increased 13% to $371.3M. Net income totaled $9.3M vs. loss of $8.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Automation and Analytics segment income increase from $25.7M to $56.3M Medication Adherence segment loss decrease of 7% to $2.1M.

 OMCLのテクニカル分析


 OMCLのニュース

   Cantor Fitzgerald Equities Analysts Increase Earnings Estimates for Omnicell, Inc. (NASDAQ:OMCL)  2021/11/04 11:18:44 Transcript Daily
Omnicell, Inc. (NASDAQ:OMCL) Cantor Fitzgerald lifted their FY2021 earnings per share (EPS) estimates for shares of Omnicell in a report issued on Wednesday, November 3rd. Cantor Fitzgerald analyst S. Halper now expects that the company will post earnings per share of $2.80 for the year, up from their previous estimate of $2.67. Other equities []
   Zacks Investment Research Downgrades Omnicell (NASDAQ:OMCL) to Hold  2021/11/03 10:24:41 Dakota Financial News
Zacks Investment Research downgraded shares of Omnicell (NASDAQ:OMCL) from a buy rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $184.00 price target on the stock. According to Zacks, Omnicell continues to battle escalating costs. In the second quarter, cost of product revenues increased []
   Insider Selling: Omnicell, Inc. (NASDAQ:OMCL) EVP Sells 5,358 Shares of Stock  2021/11/03 09:14:41 Transcript Daily
Omnicell, Inc. (NASDAQ:OMCL) EVP Dan S. Johnston sold 5,358 shares of Omnicell stock in a transaction that occurred on Tuesday, November 2nd. The shares were sold at an average price of $180.00, for a total transaction of $964,440.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through []
   Omnicell Inc (OMCL) EVP & Chief Legal & Admin Dan S Johnston Sold $964,440 of Shares  2021/11/03 03:15:04 GuruFocus
Related Stocks: OMCL ,
   Astonishing Demand of Europe Automated Dispensing Systems Market Growth Set to Surge Significantly during 2020 2027| Cerner Corporation, Capsa Healthcare, Omnicell, Inc  2021/11/02 08:37:58 OpenPR
Businessmarketinsights Latest update on Europe Automated Dispensing Systems Market Analysis, Europe Automated Dispensing Systems market growth analysis and Projection by 2027. This report is highly predictive as it holds the overall market analysis of topmost companies into the Europe
   The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq  2021/03/18 12:16:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) Urovant Sciences Ltd. (NASDAQ: UROV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 17) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) Galapagos NV (NASDAQ: GLPG ) Galecto, Inc. (NASDAQ: GLTO ) Stocks In Focus Translate Bio mRNA Product Candidate For Cystic Fibrosis Fails To Improve Lung Function In Phase 1/2 Study Translate Bio (NASDAQ: TBIO ) announced a second interim analysis from the Phase 1/2 study of MRT5005 in patients with cystic fibrosis, showing that repeat dosing was generally safe and well tolerated, with no serious adverse events.
   The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes  2021/03/17 11:43:07 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 16) Affimed N.V. (NASDAQ: AFMD ) BioAtla, Inc. (NASDAQ: BCAB ) Champions Oncology, Inc. (NASDAQ: CSBR ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Myriad Genetics, Inc. (NASDAQ: MYGN ) Omnicell, Inc. (NASDAQ: OMCL ) Savara Inc. (NASDAQ: SVRA ) (reacted to a positive analyst action and insider buying) Sierra Oncology, Inc. (NASDAQ: SRRA ) Sol-Gel Technologies Ltd. (NASDAQ: SLGL ) Vincerx Pharma, Inc. (NASDAQ: VINC ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 16) Galecto, Inc. (NASDAQ: GLTO ) Immunocore Holdings plc (NASDAQ: IMCR ) Stocks In Focus Pfizer to Sell Chinese Biologics Unit to WuXi Pfizer Inc.'s (NYSE: PFE ) China unit and Hong Kong-listed WuXi Biologics announced an equity agreement under which the latter will acquire the former's state-of-the-art biologics manufacturing facilities as well as its labor force in Hangzhou, China.
   Pharmacy Automation Market Estimated Huge Growth by 2021-2026 | BD, Baxter, TOSHO, Takazono, Omnicell, YUYAMA  2021/03/16 14:30:03 OpenPR
The global Pharmacy Automation market size is projected to grow in the historic period resulted from economic growth in emerging markets, the rise in awareness of the benefits and developed nations towards Pharmacy Automation costs and increasing production and growing
   North America Medical Carts Market Top Players Herman Miller, Inc., Omnicell, Inc., The Harloff Company  2021/03/12 11:24:29 OpenPR
North America Medical Carts Market top level players are analyzed in report based on current and future development status, and North America Medical Carts market estimations from 2020 to 2027 in terms of revenue and volume. This report provides strategic
   The Christ Hospital Health Network Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management  2021/03/03 13:01:00 Business Wire
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The Christ Hospital Health Network Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
   North America Medical Carts Market Top Players Herman Miller, Inc., Omnicell, Inc., The Harloff Company  2021/03/12 11:24:29 OpenPR
North America Medical Carts Market top level players are analyzed in report based on current and future development status, and North America Medical Carts market estimations from 2020 to 2027 in terms of revenue and volume. This report provides strategic
   The Christ Hospital Health Network Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management  2021/03/03 13:01:00 Business Wire
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The Christ Hospital Health Network Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
   Europe Automated Dispensing Systems Market to see an Exclusive Growth during 2020-2027 with Top Key Players Like Cerner Corporation, Capsa Healthcare, OMNICELL INC  2021/02/25 10:10:38 OpenPR
The Business Market Insights provides you regional research analysis on “Europe Automated Dispensing Systems Market” and forecast to 2027. The research report provides deep insights into the regional market revenue, parent market trends, macro-economic indicators, and governing factors, along with
   Pharmacy Management System Market With Leading Players like McKesson Corporation Cerner Corporation BD, General Electric Company, Allscripts Healthcare, LLC Epicor Software Corporation, Talyst LLC (Swisslog Healthcare) OMNICELL, ACG Infotech Ltd., Clanwil  2021/02/24 08:07:42 OpenPR
An off-the-shelf report on Pharmacy Management System Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such
   Omnicell Appoints Christine Mellon as Chief People Officer  2021/02/22 13:30:00 Business Wire
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Appoints Christine Mellon as Chief People Officer

 関連キーワード  (先端医療機器_テクノロジ― 米国株 オムニセル OMCL Omnicell Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)